BioMarin

$87.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.11 (+1.28%) Today

$0.00 (0.00%) As of 9:00 AM UTC after-hours

Why Robinhood?

You can buy or sell BioMarin and other stocks, options, and ETFs commission-free!

About BMRN

BioMarin Pharmaceutical Inc. Common Stock, also called BioMarin, is a biotechnology company, which engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline include Vosoritide (BMN 111) for Achondroplasia and Valoctocogene Roxaparvovec (BMN 270) for Hemophilia A. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA. The listed name for BMRN is BioMarin Pharmaceutical Inc. Common Stock.

CEO

Jean-Jacques Bienaimé

Employees

3,001

Headquarters

San Rafael, California

Founded

1997

Market Cap

16.18B

Price-Earnings Ratio

20.15

Dividend Yield

—

Average Volume

2.13M

High Today

$88.80

Low Today

$85.52

Open Price

$85.86

Volume

898.28K

52 Week High

$131.95

52 Week Low

$68.25

Collections

Analyst Ratings

61%

of 23 ratings

Buy

61%

Hold

39%

Sell

BMRN Earnings

-$0.29

$1.14

$2.58

$4.01

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 24, After Hours